MO Board of Pharmacy Statement: FDA Authorization to Prescribe Paxlovid

FDA Authorization to Prescribe Paxlovid

 The FDA recently revised their COVID-19 emergency use authorization (EUA) to allow state-licensed pharmacists to prescribe Paxlovid^™ to eligible patients, subject to specific limitations.  Pharmacists may prescribe Paxlovid^™ as authorized by the EUA.  Pharmacist must be competent to perform the services provided and must ensure patient care services are safely performed in accordance with applicable standards of care.

• Pharmacists prescribing pursuant to FDA’s authorization must comply with all FDA prescribing and documentation requirements.
• No additional Board licensure, certification or notification is required for Missouri-licensed pharmacists prescribing Paxlovid^™  under the FDA’s EUA.